Psychedelics Firm Origin Therapeutics Announced it Signed a Binding LOI With Narcotics Streaming and Investment Company Safe Supply Streaming Co. Upon...
The article Apex Labs Granted Approval for At-Home Phase 2b Psilocybin Trial was originally published on Microdose. Under-the-radar psychedelic firm Apex...
The article Numinus Receives Approval for Clinical Trial using Psilocybe Cubensis Tea was originally published on Microdose. Numinus Receives Clinical...
The article Origin Signs Letter of Intent to Acquire Safe Supply Streaming was originally published on Microdose. “We have a public health emergency...
The article News You Might Have Missed: Jan 30th, 2023 was originally published on Microdose. Welcome to the News You Might Have Missed, a weekly roundup...
The article Health Canada Approves Diamond Therapeutics’ Phase 2 Trial of Low-Dose Psilocybin was originally published on Microdose. “Building...
Investing in psychedelic companies has become increasingly popular in the past few years. Here at Psychedelic Invest, our goal is to connect you to the...
Today, Numinus Wellness Inc. (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted...
Alberta’s new policy on psychedelic-assisted therapy for mental illness may set a precedent that moves Canadians one step closer to accepting psychedelics...
Universal Ibogaine (TSX.V: IBO), a life sciences company with a mission to transform the addiction treatment industry with medicalized ibogaine-centered...